Albert B. DeLeo - Concepedia

Author

Albert B. DeLeo

UPMC Hillman Cancer Center

Also Known As

A B DeLeo, A B Deleo, A DeLeo, A Deleo, A. B. DeLeo, A. DeLeo, A. Deleo, A.B. DeLeo, A.B. Deleo, ALBERT B. DELEO

201

Publications

9.3K

Citations

H-Index

126

Concepts

All Affiliations

UPMC Hillman Cancer Center University of Pittsburgh Memorial Sloan Kettering Cancer Center Massachusetts General Hospital Harvard University

About

Albert B. DeLeo is an author at UPMC Hillman Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	62	6.6K
2	Health Sciences	4	4	214
3	Natural Sciences	4	4	252
4	Engineering	3	3	127
5	Social Sciences	1	1	14

Albert B. DeLeo

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity José Mayordomo, Tatiana Zorina, Walter J. Storkus, Nature Medicine Marrow-derived Dendritic CellsTumor ImmunologyTherapeutic Antitumour ImmunityImmunologyTumor Immunity	1995	1.1K
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. Laurence Zitvogel, José Mayordomo, Tjendimin Tjandrawan, The Journal of Experimental Medicine Host Dendritic CellsImmunologyImmunoeditingMurine TumorsCd4 T Cell Responses	1996	843
Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Albert B. DeLeo, Gregory D. Jay, Ettore Appella, Proceedings of the National Academy of Sciences ImmunologyImmunodominancePathologyAntigen ProcessingSarcoma Virus	1979	728
Tumor rejection antigens of chemically induced sarcomas of inbred mice. Pramod K. Srivastava, Albert B. DeLeo, Lloyd J. Old Proceedings of the National Academy of Sciences HistocompatibilityMurine Leukemia VirusImmunologyImmunoeditingPathology	1986	455
Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. William H. Chambers, Nikola L. Vujanović, Albert B. DeLeo, The Journal of Experimental Medicine AllergyAutoimmune DiseaseTriggering StructureMedicineImmunology	1989	363
Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. W E Mercer, Douglas L. Nelson, Albert B. DeLeo, Proceedings of the National Academy of Sciences XenotransplantationMedicineImmunologyImmunoeditingCancer Cell Biology	1982	277
Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines. José Mayordomo, Douglas J. Loftus, Hiroshi Sakamoto, The Journal of Experimental Medicine ImmunologyImmunoeditingPathologyMurine TumorsImmunotherapy	1996	255
Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. Albert B. DeLeo, Hiroshi Shiku, Takashi Takahashi, The Journal of Experimental Medicine Murine Leukemia VirusImmunocytochemical TechniqueLaboratory ImmunologyImmunologyImmunodominance	1977	228
p53 transformation-related protein: Detection by monoclonal antibody in mouse and human cells Wolfgang Dippold, Albert B. DeLeo, George Khoury, Proceedings of the National Academy of Sciences	1981	213
Characterization of the antitumor activities of human tumor necrosis factor-<i>alpha</i> and the comparison with other cytokines: induction of tumor-specific immunity. Michael A. Palladino, M R Shalaby, Susan M. Kramer, The Journal of Immunology	1987	200

Page 1